CIBC Private Wealth Group
GOSS icon

CIBC Private Wealth Group’s Gossamer Bio GOSS Stock Holding History

CIBC Private Wealth Group’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-13
Closed -$986 – 3064
2024
Q3 		$986 Buy
+13
New +$1K ﹤0.01% 2911

Other funds holding GOSS

OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $38.9B AUM 28.51% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $962M AUM 524.64% 1-Year Est. Return
SB
Samsara BioCapital Palo Alto, California $1.22B AUM 242.83% 1-Year Est. Return

CIBC Private Wealth Group's GOSS Position: Q4 2024 in Review

CIBC Private Wealth Group sold out of Gossamer Bio (GOSS) in Q4 2024, closing a stake of 13 shares — an estimated $986 sold.

CIBC Private Wealth Group first reported a position in GOSS in Q3 2024 and held it in 1 quarter. The position peaked at $986 in Q3 2024. 102 funds tracked by Wall St. Rank hold GOSS as of Q4 2024.

  • CIBC Private Wealth Group reported no remaining Gossamer Bio position as of Q4 2024 after selling out during the quarter.
  • CIBC Private Wealth Group sold 13 Gossamer Bio shares in Q4 2024, an estimated $986.
  • CIBC Private Wealth Group first reported a position in Gossamer Bio in Q3 2024 and held it in 1 quarter.
  • CIBC Private Wealth Group's Gossamer Bio position peaked at $986 in Q3 2024.
  • 102 funds tracked by Wall St. Rank held Gossamer Bio as of Q4 2024.

Based on CIBC Private Wealth Group's 13F filing for Q4 2024, filed 12 Feb 2025.